Baker Norton Pharmaceutical

Baker Norton Pharmaceutical was a pharmaceutical company that operated as a subsidiary of IVAX Corporation. Formed through the merger of Baker Cummins and Norton, the company specialized in the development and commercialization of a diverse range of therapeutic products. Its portfolio included notable drugs such as Elmiron for interstitial cystitis, Paxene (paclitaxel) for oncology, and Proventil (albuterol) for respiratory conditions. In 1992, the company expanded its global footprint by establishing Kunming Baker Norton Pharmaceutical Co. Ltd. (KBN), a prominent joint venture in China with KPC Pharmaceuticals. Following Teva Pharmaceutical Industries' acquisition of IVAX in 2006, Baker Norton's assets and operations were integrated into Teva's global business. The company is also recognized for its role in landmark patent litigation that helped shape legal standards for pharmaceutical administration methods.